MBX
MBX Biosciences Inc.

148
Loading...
Loading...
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
43

Frequently Asked Questions

What is Market Cap of MBX Biosciences Inc.?
What is the 52-week high for MBX Biosciences Inc.?
What is the 52-week low for MBX Biosciences Inc.?
What is MBX Biosciences Inc. stock price today?
What was MBX Biosciences Inc. stock price yesterday?
What is the PE ratio of MBX Biosciences Inc.?
What is the Price-to-Book ratio of MBX Biosciences Inc.?
What is the 50-day moving average of MBX Biosciences Inc.?
How many employess does MBX Biosciences Inc. has?

Latest MBX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.